Site Search
Professionals 345 results
- Peter Crowther
- International Managing Partner
- +44 20 7011 8750
- vCard
International Managing Partner
Capabilities 75 results
Industry
Practice Area
eDiscovery & Information Governance
Winston’s eDiscovery & Information Governance Practice (eDiscovery Group) is one of the United States’ largest and most experienced. Per The Legal 500 US 2024, “[Winston has] a very strong practice from top to bottom. They have a good e-discovery consulting practice and excellent review and production capabilities and are amongst the strongest advocates you could want in a courtroom.” We have built a full-service consulting practice to support our clients and case teams in these complex areas—both domestically and globally.
Experience 61 results
Insights & News 3,505 results
Client Alert
|June 12, 2025
|3 Min Read
Reforming the Nuclear Regulatory Commission: An Overview of President Trump’s May 23 Executive Order
On May 23, 2025, President Trump signed an executive order titled “Ordering the Reform of the Nuclear Regulatory Commission” (EO) aimed at accelerating and expanding the nuclear energy industry in the United States. The EO directs a comprehensive structural reorganization of the Nuclear Regulatory Commission (NRC) and an overhaul of its regulatory framework related to the licensing and deployment of advanced nuclear reactors.
Client Alert
|June 12, 2025
|3 Min Read
Oregon Enacts SB 951, Restricting PE-Backed MSOs in Physician Practice Transactions
On June 9, 2025, Oregon enacted Senate Bill 951 (SB 951), a sweeping new law significantly limiting how management services organizations (MSOs)—including those backed by private-equity firms—may engage with physician practices. The legislation targets traditional “friendly provider” models by restricting ownership and operational control of professional medical entities and voiding restrictive covenants. Investors must now reassess Oregon-based physician practice investments to ensure compliance by 2026 (for new MSOs) and 2029 (for existing ones). It’s noteworthy that this law will coexist with Oregon’s complicated health care transactions notice law, a law that requires a thorough review of certain health care transactions.
Client Alert
|June 12, 2025
|6 Min Read
Safeguarding Public Health Grants: How States Fought Against Abrupt Federal Funding Cuts
On May 16, 2025, the U.S. District Court for the District of Rhode Island granted a Motion for a Preliminary Injunction against the Department of Health and Human Services (HHS) and Secretary of Health and Human Services Robert F. Kennedy Jr.[1] As a result, HHS must continue to provide access to healthcare-related funding to the 23 plaintiff States and the District of Columbia (the States) after attempting to unilaterally terminate access to those funds, and it may not “tak[e] any action to reinstitute” the terminations “for the same or similar reasons.”[2]
Other Results 64 results
Law Glossary
What Is an Inter Partes Review (IPR)?
An inter partes review of a patent is a type of administrative trial proceeding. Inter partes review became available in 2012 and replaced inter partes reexamination as a way to challenge patentability at the Patent Office. Any person who is not the owner of a patent can file a petition for a review of a patent. The Patent Trial and Appeal Board (PTAB) will act on the petition either instituting a trial or denying institution of a trial. This will occur a little over six months after the petition is filed. If trial is instituted, the proceeding will, with some limited exceptions, be resolved within one year.
Law Glossary
What Is the Patent Trial and Appeal Board?
The Patent Trial and Appeal Board (PTAB) is a tribunal within U.S. Patent and Trademark Office. The PTAB oversees trial proceedings, namely: inter partes review (IPR), post-grant review (PGR), covered business method (CBM) review, and derivation proceedings. The Board also hears appeals from adverse patentability decisions by patent examiners in original applications, reissues, and reexaminations. And, while phasing out since the passage of the America Invents Act (AIA) in 2011, the PTAB is also responsible for deciding interferences. The PTAB was previously referred to as the Board of Patent Appeals and Interferences and was renamed by the AIA.
Law Glossary
A post-grant review, or PGR, is a trial proceeding where the patentability of one or more claims in a patent is reviewed. The review process begins when a third party, who is not the patent owner, files a petition within nine months of a patent being granted or reissued. This filing challenges a patent’s claim or claims based upon a specific ground. The Patent Trial and Appeal Board (PTAB) is the branch of the U.S. Patent and Trademark Office that handles the trial proceeding. The post-grant review can be filed on any grounds that are available to dispute the validity of a patent claim, except for the following: failure to disclose the best mode requirement.